Search
forResearch 10 of 1000+
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- Ductal breast cancer in a male patient
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- Sex Steroid Hormone Receptors in Human Skin Appendage and its Neoplasms
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
Community 3 of 192
- Theaflavin (Black Tea Extract) reduce DHT, androgen receptor activity and estrogen
- If we lose hair because of our sensitivity to DHT, then why are we trying to reduce DHT when our sensitive androgen receptors are the culprit?
- High Estrogen causing hair loss?
Learn
— no results
Try a deeper search in learn →